Gene Expression of Sirtuin-1 and Endogenous Secretory Receptor for Advanced Glycation End Products in Healthy and Slightly Overweight Subjects after Caloric Restriction and Resveratrol Administration.
Roggerio, Alessandra; Strunz, Célia M Cassaro; Pacanaro, Ana Paula; Leal, Dalila Pinheiro; Takada, Julio Y; Avakian, Solange D; Mansur, Antonio de Padua.
; 10(7)2018 Jul 21.
Artigo em Inglês | MEDLINE | ID: mdl-30037068
Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon ß-1a.
All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastoris.
Ligand binding affinity and changes in the lateral diffusion of receptor for advanced glycation endproducts (RAGE).
Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
An improved expression system for the VC1 ligand binding domain of the receptor for advanced glycation end products in Pichia pastoris.
HMGB1 and RAGE in inflammation and cancer.
RAGE Plays a Role in LPS-Induced NF-κB Activation and Endothelial Hyperpermeability.
Temporal reliability of serum soluble and endogenous secretory receptors for advanced glycation end-products (sRAGE and esRAGE) in healthy women.
Ratio of serum levels of AGEs to soluble RAGE is correlated with trimethylamine-N-oxide in non-diabetic subjects.